- Home
- OABI vs PSNYW Comparison
OABI vs PSNYW Comparison
Compare OABI & PSNYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OABI | PSNYW |
|---|---|---|
| Founded | 2012 | 2017 |
| Country | United States | Sweden |
| Employees | 114 | 2547 |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 253.4M | 290.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OABI | PSNYW |
|---|---|---|
| Price | $1.89 | $4.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.67 | N/A |
| AVG Volume (30 Days) | ★ 284.4K | 5.6K |
| Earning Date | 01-01-0001 | 03-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $2,034,261,000.00 |
| Revenue This Year | $74.84 | N/A |
| Revenue Next Year | $40.54 | $79.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.22 | $0.13 |
| 52 Week High | $3.33 | $7.50 |
Technical Indicators
Market Signals| Indicator | OABI | PSNYW |
|---|---|---|
| Relative Strength Index (RSI) | 58.19 | 65.26 |
| Support Level | $1.85 | $0.18 |
| Resistance Level | $2.15 | $5.99 |
| Average True Range (ATR) | 0.10 | 0.56 |
| MACD | 0.03 | 0.21 |
| Stochastic Oscillator | 61.54 | 87.81 |
Price Performance
Historical ComparisonAbout OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.